FDA approves first new sickle cell drug in 20 years
The FDA approved a new medicine, made by Emmaus Medical, Friday to reduce the complications associated with sickle cell disease, a rare blood disorder.
by Adam Feuerstein
Jul 07, 2017
1 minute
The FDA approved a new medicine Friday to reduce the complications associated with sickle cell disease, a rare blood disorder.
The drug, Endari, is made
You’re reading a preview, subscribe to read more.
Start your free 30 days